These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11817973)

  • 1. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    Drugs; 2002; 62(2):265-84. PubMed ID: 11817973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    Curr Hypertens Rep; 2000 Feb; 2(1):64-70. PubMed ID: 10981130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antihypertensive treatment on endothelial function.
    Virdis A; Ghiadoni L; Taddei S
    Curr Hypertens Rep; 2011 Aug; 13(4):276-81. PubMed ID: 21499710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of antihypertensive drugs on endothelial dysfunction.
    Puddu P; Puddu GM; Cravero E; Muscari A
    Acta Cardiol; 2004 Oct; 59(5):555-64. PubMed ID: 15529563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Pasini AF; Garbin U; Cominacini L; Salvetti A
    J Hypertens; 2001 Aug; 19(8):1379-86. PubMed ID: 11518845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endothelial function and arterial hypertension].
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():85S-90S. PubMed ID: 8562274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and endothelial dysfunction: therapeutic approach.
    Ghiadoni L; Taddei S; Virdis A
    Curr Vasc Pharmacol; 2012 Jan; 10(1):42-60. PubMed ID: 22112351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effect of antihypertensive drugs on conduit artery endothelial function.
    Ghiadoni L; Magagna A; Versari D; Kardasz I; Huang Y; Taddei S; Salvetti A
    Hypertension; 2003 Jun; 41(6):1281-6. PubMed ID: 12719441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium, atherosclerosis and calcium channel blockers.
    Biswas TK
    J Indian Med Assoc; 2003 Jul; 101(7):428-31. PubMed ID: 14748381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation.
    Silva IVG; de Figueiredo RC; Rios DRA
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting endothelial dysfunction in hypertensive subjects.
    Thuillez C; Richard V
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic factors in hypertension. Endothelial factors.
    Taddei S; Salvetti A
    Clin Exp Hypertens; 1996; 18(3-4):323-35. PubMed ID: 8743024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal vascular protection: a case for combination antihypertensive therapy.
    Vogel RA
    Prev Cardiol; 2006; 9(1):35-41. PubMed ID: 16407701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction in hypertension.
    Puddu P; Puddu GM; Zaca F; Muscari A
    Acta Cardiol; 2000 Aug; 55(4):221-32. PubMed ID: 11041120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.
    Van Bortel LM; Fici F; Mascagni F
    Am J Cardiovasc Drugs; 2008; 8(1):35-44. PubMed ID: 18303936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide.
    Landmesser U; Drexler H
    J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients.
    Virdis A; Ghiadoni L; Qasem AA; Lorenzini G; Duranti E; Cartoni G; Bruno RM; Bernini G; Taddei S
    Eur Heart J; 2012 Jun; 33(12):1530-8. PubMed ID: 22450428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
    Shahin Y; Khan JA; Samuel N; Chetter I
    Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.
    Lüscher TF; Yang Z
    Drugs; 1993; 46 Suppl 2():121-32. PubMed ID: 7512465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.